Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Paul J. Dluzniewski"'
Autor:
Demetria Hubbard, Emily C. McKinley, Lisandro D. Colantonio, Bharat Poudel, Robert S. Rosenson, Todd M. Brown, Elizabeth A. Jackson, Lei Huang, Kate K. Orroth, Katherine E. Mues, Paul J. Dluzniewski, Vera Bittner, Paul Muntner
Publikováno v:
American Heart Journal Plus, Vol 13, Iss , Pp 100121- (2022)
Study objective: Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) and sodium-glucose cotransporter-2 inhibitors (SGLT2i) reduce the risk for atherosclerotic cardiovascular disease (ASCVD) events in patients with diabetes and ASCVD. W
Externí odkaz:
https://doaj.org/article/13e6ea4063bf43b5b251b7b09204fff3
Autor:
Bharat Poudel, Robert S. Rosenson, Vera Bittner, Orlando M. Gutiérrez, Amanda H. Anderson, Mark Woodward, Rajat Deo, April P. Carson, Katherine E. Mues, Paul J. Dluzniewski, Bernard G. Jaar, Claudia M. Lora, Jonathan Taliercio, Paul Muntner, Lisandro D. Colantonio
Publikováno v:
Kidney Medicine, Vol 3, Iss 5, Pp 722-731.e1 (2021)
Rationale & Objective: The 2018 American Heart Association/American College of Cardiology (AHA/ACC) cholesterol guideline uses risk stratification to guide the decision to initiate nonstatin lipid-lowering medication among adults with atherosclerotic
Externí odkaz:
https://doaj.org/article/5a204940bce24d98869a281e3340859a
Autor:
Douglas S. Fuller, David Hallett, Paul J. Dluzniewski, Bruno Fouqueray, Michel Jadoul, Hal Morgenstern, Friedrich K. Port, Francesca Tentori, Ronald L. Pisoni
Publikováno v:
BMC Nephrology, Vol 20, Iss 1, Pp 1-13 (2019)
Abstract Background The putative benefits of cinacalcet therapy for management of secondary hyperparathyroidism (SHPT) are thought to be most manifested when patients are taking it consistently and as prescribed. Real-world descriptions of cinacalcet
Externí odkaz:
https://doaj.org/article/18551c5e8d794d849dd15c3b73e5582e
Autor:
Robert S. Rosenson, Demetria Hubbard, Keri L. Monda, Stephanie R. Reading, Ligong Chen, Paul J. Dluzniewski, Greer A. Burkholder, Paul Muntner, Lisandro D. Colantonio
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 1 (2020)
Background In the 2000s, adults with HIV had a higher risk for atherosclerotic cardiovascular disease (ASCVD) compared with those without HIV. There is uncertainty if this excess risk still exists in the United States given changes in antiretroviral
Externí odkaz:
https://doaj.org/article/fc110e86a996431b8e5b106f2a2037ec
Autor:
Paul J. Dluzniewski, James B. Wetmore, Haifeng Guo, Kimberly Nieman, David T. Gilbertson, Brian D. Bradbury, J. Michael Sprafka, Yi Peng, Tzu-Chieh Lin, Jiannong Liu
Publikováno v:
Pharmacoepidemiology and Drug Safety. 31:141-148
Purpose Secondary hyperparathyroidism (SHPT) is common among dialysis patients, and calcimimetics are a mainstay of treatment. This study assessed whether cinacalcet use is associated with gastrointestinal bleeding in a large hemodialysis cohort. Met
Autor:
Paul J. Dluzniewski, Paul Muntner, Yuling Dai, Mark Woodward, Michael E. Farkouh, Lisandro D. Colantonio, Hong Zhao, Bharat Poudel, Sanne A.E. Peters, Vera Bittner
Publikováno v:
Circulation. 143:650-660
Background: Rates for recurrent coronary heart disease (CHD) events have declined in the United States. However, few studies have assessed whether this decline has been similar among women and men. Methods: Data were used from 770 408 US women and 70
Autor:
M. Alan Brookhart, Diane Reams, Kiran Philip, Leah J. McGrath, Paul J. Dluzniewski, Ying Yu, Sara N. Levintow, Bradley Saul, Stephanie R. Reading
Publikováno v:
Clinical Epidemiology. 12:835-845
Background The 2013 ACC/AHA cholesterol treatment guidelines removed the recommendation to treat adults at risk of cardiovascular disease to goal levels of low-density lipoprotein cholesterol (LDL-C). We anticipated that the frequency of LDL-C testin
Autor:
Kerry Cooper, Brian D. Bradbury, Douglas S. Fuller, Paul J. Dluzniewski, Francesca Tentori, Bruce M. Robinson
Publikováno v:
Clinical Kidney Journal
BackgroundPrior studies have developed a chronic kidney disease–mineral and bone disorder (CKD-MBD) composite score based on combinations of calcium (Ca), phosphorus (P) and parathyroid hormone (PTH) that have been shown to be associated with an in
Autor:
Bertil Lindahl, Andrew Hamer, Tomas Jernberg, Stephanie R. Reading, Håkan Melhus, Henrik Renlund, Margret Leosdottir, Emil Hagström, Peter Ueda, J Schubert, Ali Yari, Stefan James, Paul J. Dluzniewski
Publikováno v:
European Heart Journal
Aims Clinical trials have demonstrated that a reduction in low-density lipoprotein cholesterol (LDL-C) reduces cardiovascular (CV) events. This has, however, not yet been shown in a real-world setting. We aimed to investigate the association between
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be98f2527ea77a9a1d9d222bff0c15dd
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-430124
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-430124
Autor:
Bharat Poudel, Michael E. Farkouh, Ligong Chen, Paul J. Dluzniewski, Sanne A.E. Peters, Vera Bittner, Mark Woodward, Paul Muntner, Lisandro D. Colantonio
Publikováno v:
European Heart Journal. 41
Background Women have lower age-specific rates of incident coronary heart disease (CHD) than men. However, it remains unclear whether women maintain the same advantage once they have had a cardiac event. Purpose To assess whether sex differences in t